4.6 Article

Early Cellular, Molecular, Morphological and Behavioral Changes in the Humanized Amyloid-Beta-Knock-In Mouse Model of Late-Onset Alzheimer's Disease

Related references

Note: Only part of the references are listed.
Article Cell Biology

Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria

Prashanth Gowda et al.

Summary: Alzheimer's disease is the most common cause of dementia, with a focus on mitochondrial dysfunction in neurons. Research is centered around mitochondrial miRNAs and their regulatory roles in mitochondrial and synaptic functions. However, more research is needed to confirm the specific locations and roles of individual mitochondrial miRNAs in the development of AD.

AGEING RESEARCH REVIEWS (2022)

Article Biochemistry & Molecular Biology

Protective effects of a small-molecule inhibitor DDQ against tau-induced toxicities in a transgenic tau mouse model of Alzheimer's disease

Murali Vijayan et al.

Summary: The purpose of this study was to determine the protective effects of DDQ on phosphorylated tau in Alzheimer's disease. The researchers administered DDQ to tau transgenic mice and assessed its levels in different tissues. They also measured the mRNA and protein levels of genes related to mitochondrial dynamics, biogenesis, synaptic function, and longevity. The results showed that DDQ had the greatest impact on skeletal muscle, leading to increased levels of mitochondrial fusion and biogenesis, as well as decreased levels of mitochondrial fission and phosphorylated tau.

HUMAN MOLECULAR GENETICS (2022)

Article Biochemistry & Molecular Biology

Protective effects of mitophagy enhancers against amyloid beta-induced mitochondrial and synaptic toxicities in Alzheimer disease

Sudhir Kshirsagar et al.

Summary: The study aims to determine the protective effects of mitophagy enhancers against mitochondrial and synaptic toxicities in Alzheimer's disease, and to optimize the treatment of mutant APP-induced mitochondrial abnormalities using mitophagy enhancers.

HUMAN MOLECULAR GENETICS (2022)

Article Clinical Neurology

The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer's disease

David C. Hondius et al.

Summary: This study provides a comprehensive assessment of protein abundances in neurons with granulovacuolar degeneration (GVD) and those bearing neurofibrillary tangles (NFTs) in Alzheimer's disease (AD) patients. The research revealed significant changes in protein composition in GVD and tangle-bearing neurons, with proteins related to protein folding, proteasomal function, endolysosomal pathway, and microtubule function being affected in GVD neurons. The study suggests that GVD is part of a pre-NFT stage in AD pathogenesis and may disrupt proteostasis and cellular homeostasis.

ACTA NEUROPATHOLOGICA (2021)

Review Cell Biology

Synaptic basis of Alzheimer's disease: Focus on synaptic amyloid beta, P-tau and mitochondria

Albin John et al.

Summary: Alzheimer's disease is a progressive disease associated with synaptic dysfunction, with researchers striving to find more information on disease progression and pathogenesis. Synaptic pathology and mitochondrial oxidative damage are early events in the progression of AD, with synaptic loss and damage being key correlates of cognitive deficits in patients. As the disease advances, significant changes occur at the synapse, shedding light on the disease progression and serving as potential markers and therapeutic targets.

AGEING RESEARCH REVIEWS (2021)

Review Clinical Neurology

Early-Onset Alzheimer's Disease: What Is Missing in Research?

Temitope Ayodele et al.

Summary: EOAD, occurring before age 65, is less studied than LOAD despite its aggressive disease progression. Only a fraction of the genetic variation has been identified, leaving the molecular mechanisms unclear. Further research is needed to identify potential targets for disease screening, diagnosis, prevention, and treatment.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2021)

Review Biochemistry & Molecular Biology

Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation

Hossein Ashrafian et al.

Summary: Approximately 40 million people globally suffer from dementia, with Alzheimer's disease being the most common cause. Aggregation of Aβ outside of neuron cells and tau protein tangle formation inside cells are believed to play crucial roles. This paper reviews studies targeting the inhibition of these protein aggregations to suppress or postpone AD.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)

Article Biochemistry & Molecular Biology

MicroRNA-455-3p improves synaptic, cognitive functions and extends lifespan: Relevance to Alzheimer's disease

Subodh Kumar et al.

Summary: The study found that miR-455-3p has a protective role in mouse models, prolonging lifespan, improving cognitive function, and enhancing mitochondrial and synaptic activities. Conversely, depletion of miR-455-3p leads to impaired physiological functions and shortened lifespan.

REDOX BIOLOGY (2021)

Article Neurosciences

Anti-brain Aging Effects of Small Molecule Inhibitor DDQ

Murali Vijayan et al.

Summary: The study aimed to investigate the protective effects of the newly discovered molecule DDQ against aging, with 20 mg/kg body weight showing the strongest protective effects in mice. DDQ was found to upregulate longevity genes SIRTUINS and significantly increase dendritic spines and mitochondrial quality.

MOLECULAR NEUROBIOLOGY (2021)

Article Multidisciplinary Sciences

Generation of a humanized Aβ expressing mouse demonstrating aspects of Alzheimer's disease-like pathology

David Baglietto-Vargas et al.

Summary: The researchers created a mouse model that expresses wildtype human A β, demonstrating effects on cognition, synaptic plasticity, brain changes, inflammation, PAS granules, and gene expression. Furthermore, excision of exon 14 through Cre-mediated methods reduced A β expression and rescued cognitive impairments.

NATURE COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse

Hallie Morton et al.

Summary: Alzheimer's disease is a progressive neurodegenerative disease characterized by multiple cellular changes, mitochondrial dysfunction, and brain damage, ultimately leading to cognitive impairment.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Article Cell Biology

Protective effects of a small molecule inhibitor, DDQ against amyloid beta in Alzheimer's disease

Murali Vijayan et al.

Summary: The study investigated the protective effects of DDQ against mutant APP and amyloid-beta in Alzheimer's disease, showing that DDQ could ameliorate cognitive decline, improve working memory, enhance exploratory behavior, and promote motor coordination in APP mice. Furthermore, it was found that DDQ upregulated longevity genes, mitochondrial biogenesis, and synaptic genes in the treated mice, indicating its potential anti-aging and anti-amyloid-beta effects.

MITOCHONDRION (2021)

Review Neurosciences

Age-Related Chronic Diseases and Alzheimer's Disease in Texas: A Hispanic Focused Study

Shyam Sheladia et al.

Summary: The increase in age-related chronic diseases in the United States directly contributes to the development of dementia, with both unmodifiable and modifiable risk factors playing a role. Hispanic Americans in the U.S. are particularly vulnerable to dementia and also face challenges in accessing healthcare services.

JOURNAL OF ALZHEIMERS DISEASE REPORTS (2021)

Review Neurosciences

Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances

Wenzhang Wang et al.

MOLECULAR NEURODEGENERATION (2020)

Article Clinical Neurology

Exploratory analysis of mtDNA haplogroups in two Alzheimer's longitudinal cohorts

Russell H. Swerdlow et al.

ALZHEIMERS & DEMENTIA (2020)

Review Cell Biology

Defective mitophagy in Alzheimer's disease

Jangampalli Adi Pradeepkiran et al.

AGEING RESEARCH REVIEWS (2020)

Review Medicine, General & Internal

ApoE4: an emerging therapeutic target for Alzheimer's disease

Mirna Safieh et al.

BMC MEDICINE (2019)

Review Neurosciences

The neuropathological diagnosis of Alzheimer's disease

Michael A. DeTure et al.

MOLECULAR NEURODEGENERATION (2019)

Review Clinical Neurology

Alzheimer's disease

C. A. Lane et al.

EUROPEAN JOURNAL OF NEUROLOGY (2018)

Review Neurosciences

Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease

Fuyuki Kametani et al.

FRONTIERS IN NEUROSCIENCE (2018)

Review Neurosciences

Animal models of neurodegenerative diseases

Ted M. Dawson et al.

NATURE NEUROSCIENCE (2018)

Review Neurosciences

ALZHEIMER DISEASE Rodent models for Alzheimer disease

Juergen Goetz et al.

NATURE REVIEWS NEUROSCIENCE (2018)

Review Neurosciences

Practical considerations for choosing a mouse model of Alzheimer's disease

Joanna L. Jankowsky et al.

MOLECULAR NEURODEGENERATION (2017)

Review Biochemistry & Molecular Biology

Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?

Subodh Kumar et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)

Review Neurosciences

Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years

Patrick L. McGeer et al.

JOURNAL OF ALZHEIMERS DISEASE (2016)

Review Medicine, General & Internal

Amyloid-Beta: A Crucial Factor in Alzheimer's Disease

Saeed Sadigh-Eteghad et al.

MEDICAL PRINCIPLES AND PRACTICE (2015)

Review Biochemistry & Molecular Biology

Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: Implications for early intervention and therapeutics

Peizhong Mao et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)

Article Biochemistry & Molecular Biology

Human and rodent amyloid-β peptides differentially bind heme: Relevance to the human susceptibility to Alzheimer's disease

Hani Atamna et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2009)

Review Neurosciences

Mitochondrial Medicine for Aging and Neurodegenerative Diseases

P. Hemachandra Reddy

NEUROMOLECULAR MEDICINE (2008)

Review Biochemistry & Molecular Biology

Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease

P. Hemachandra Reddy et al.

TRENDS IN MOLECULAR MEDICINE (2008)

Review Neurosciences

Intracellular amyloid-β in Alzheimer's disease

Frank M. LaFerla et al.

NATURE REVIEWS NEUROSCIENCE (2007)

Article Multidisciplinary Sciences

Alzheimer's disease is a synaptic failure

DJ Selkoe

SCIENCE (2002)

Review Physiology

Alzheimer's disease: Genes, proteins, and therapy

DJ Selkoe

PHYSIOLOGICAL REVIEWS (2001)